Glutamate carboxypeptidase II is not an amyloid peptide-degrading enzyme

Structure-Activity Relationships of Glutamate Carboxypeptidase II (GCPII) Inhibitors

(2012) D. V. Ferraris et al.   CURRENT MEDICINAL CHEMISTRY

Glutamate Carboxypeptidase II: An Overview of Structural Studies and Their Importance for Structure-Based Drug Design and Deciphering the Reaction Mechanism of the Enzyme

(2012) J. Pavlicek et al.   CURRENT MEDICINAL CHEMISTRY

GCPII Variants, Paralogs and Orthologs

(2012) K. Hlouchova et al.   CURRENT MEDICINAL CHEMISTRY

Glutamate Carboxypeptidase II in Diagnosis and Treatment of Neurologic Disorders and Prostate Cancer

(2012) C. Barinka et al.   CURRENT MEDICINAL CHEMISTRY

Glutamate carboxypeptidase II: an amyloid peptide-degrading enzyme with physiological function in the brain

(2010) Min-Ju Kim et al.   FASEB JOURNAL

Reaction Mechanism of Glutamate Carboxypeptidase II Revealed by Mutagenesis, X-ray Crystallography, and Computational Methods

(2009) Vojtěch Klusák et al.   BIOCHEMISTRY

Oral administration of the NAALADase inhibitor GPI-5693 attenuates cocaine-induced reinstatement of drug-seeking behavior in rats

(2009) Xiao-Qing Peng et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Inhibition of NAALADase by 2-PMPA attenuates cocaine-induced relapse in rats: a NAAG-mGluR2/3-mediated mechanism

(2009) Zheng-Xiong Xi et al.   JOURNAL OF NEUROCHEMISTRY

Glutamate Carboxypeptidase Inhibition Reduces the Severity of Chemotherapy-Induced Peripheral Neurotoxicity in Rat

(2009) Valentina A. Carozzi et al.   NEUROTOXICITY RESEARCH